期刊文献+

和厚朴酚抑制白血病U937细胞侵袭及血管新生作用 被引量:3

Honokiol inhibits the invasion and angiogenesis of U937 leukemia cells
下载PDF
导出
摘要 目的探讨和厚朴酚(HNK)对人白血病U937细胞侵袭及血管新生作用的影响及其可能的分子机制。方法应用不同浓度的HNK处理U937细胞不同时间,用MTT法检测HNK对细胞增殖抑制作用;基质黏附试验检测HNK对U937细胞黏附功能的影响;TranswellTM小室检测HNK对U937细胞侵袭抑制作用。实时定量PCR(qRT-PCR)检测血管内皮生长因子(VEGF)、血管内皮生长因子受体1(VEGFR1)、基质金属蛋白酶9(MMP-9)mRNA水平变化。ELISA检测HNK处理U937细胞后上清VEGF蛋白表达水平。结果 HNK对U937的体外增殖有显著抑制作用,呈剂量和时间依赖性。低浓度HNK能够抑制U937细胞的黏附及侵袭能力。不同浓度HNK处理U937细胞24 h后,细胞VEGF、VEGFR1及MMP-9表达水平呈剂量依赖性下调。结论 HNK可能通过抑制VEGF、VEGFR1及MMP-9表达,抑制U937细胞侵袭及血管新生功能。 Objective To investigate the inhibiting effect of Honokiol (HNK) on the invasion and angiogenesis in U937 leukemia cells and the molecular mechanism. Methods After treated with different concentrations of HNK, the growth inhibition rate of U937 cells was determined by M'l-r assay, and for the adhesion and invasion abilities were assessed using cell matrix adhesion technique and TranswellTM assay, respectively. VEGF, VEGFR1 and MMP-9 mRNA expression levels were detected by real-time quantitative RT-PCR (qRT-PCR). VEGF protein levels were determined by ELISA. Results HNK could significantly inhibit the proliferation of U937 cells in a time- and dose-dependent manner. The adhesion and invasion abilities of U937 cells were suppressed after treated with a low concentration of HNK. The expressions of VEGF, VEGFR1 and MMP-9 were down-regulated by HNK in a dose-dependent manner. Conclusion HNK can inhibit the invasion and angiogenesis of U937 cells via down-regulating VEGF, VEGFR1 and MMP-9 expressions.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第2期143-146,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 河北省科技攻关计划项目(072761130)
关键词 和厚朴酚 U937细胞系 血管新生 血管内皮生长因子 Honokiol U937 cell line angiogenesis VEGF
  • 相关文献

参考文献15

  • 1成志勇,张昕,王哲,王卫红,孙雪姗,李琳,王亚丽,颜晓燕,潘崚.PTEN和COX-2在髓系白血病中的表达及作用机制探讨[J].中华检验医学杂志,2012,35(2):165-169. 被引量:10
  • 2陈浩,师亮,杨晓阳,郭晓玲,潘峻.Ang-1在多发性骨髓瘤患者中的表达及临床意义[J].中华血液学杂志,2010,31(10):654-658. 被引量:4
  • 3Zhiyong C, Wentong L, Xiaoyang Y, et al. PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia[J]. Med Oncol, 2012, 29(2) : 1084 -1092.
  • 4Li WW, Hutnik M, Gehr G. Antiangiogenesis in haen~ological malignancies [J]. BrJ Haematol, 2008, 143(5) : 622 -631.
  • 5Li Z, Liu Y, Zhao X, et al. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells [ J ]. Eur J Obstet Gynecol Reprod Biol, 2008, 140 (1) : 95 - 102.
  • 6Bai X, Cerimele F, Ushio-Fukai M, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vim[J]. J Biol Chem, 2003, 278(37) : 35501 -35507.
  • 7Wen J, Fu AF, Chen LJ, et al. Liposomal honokiol inhibits VEGF- D-induced lymphangiogenesis and metastasis in xenograft tumor model[J]. Int J Cancer, 2009, 124(11) : 2709 -2718.
  • 8Kapoor S. Attenuation of tumor growth by honokiol: an evolving role in oncology[J]. Drug Discov Ther, 2012, 6(6) : 327 -328.
  • 9Singh T, Katiyar SK. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE2-mediated activation of [3-catenin signaling[J/OA]. PLoS One, 2013, 8(4) : e60749.
  • 10Piechnik A, Dmoszynska A, Omiotek M, et al. The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients [ J ]. lnt J Cancer, 2013, 133 ( 6 ) : 1489 - 1496.

二级参考文献14

  • 1Secchiero P, Barbarotto E, Gonelli A, et al. Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.Am J Pathol,2005,167:1599-1607.
  • 2Atik E, Akansu B, Bakaris S, et al. Expression of cyclooxygenase-2 and its relation to histological grade,inducible nitric oxide synthase, matrix metalloproteinase-2, CD-34,Caspase-3,and CD8 in invasive ductal carcinoma of the breast Saudi Med J,2010,31:130-134.
  • 3St-Germain ME,Gagnon V,Mathieu 1,et al.Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.Int J Oncol,2004,24:1311-1324.
  • 4Chu EC,Chai J,Tarnawski AS.NSAIDs activate PTEN and other phosphatases in human colon cancer cells:novel mechanism for chemopreventive action of NSAIDs. Biochem Biophys Res Commun,2004,320:875-879.
  • 5Jotta PY,Ganazza MA,Silva A,et al.Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.Leukemia,2010,24:239-242.
  • 6Yang J,Liu J,Zheng J,et al.A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia.Leukemia,2007,21:2072-2074.
  • 7Montiel-Duarte C,Cordeu L,Agile X,et al. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation.Leuk Res,2008,32:709-716.
  • 8Honjo S,Osaki M,Ardyanto TD,et al. COX-2 inhibitor,NS398,enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines. DNA Cell Biol,2005,24:141-147.
  • 9Myers MP,Stolarov JP,Eng C,et al.PTEN,the tmor sppressor from human chromosome 10q23,is a dual-specificity phosphatase.Proc Natl Acad Sci USA, 1997, 94:9052-9057.
  • 10李伯利,陈葆国,罗文达,梅丽萍,颜卫华,朱敏,许惠惠.急性白血病PTEN mRNA表达和Akt磷酸化水平的相关性研究[J].中华检验医学杂志,2007,30(10):1138-1142. 被引量:2

共引文献12

同被引文献59

引证文献3

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部